Report cover image

Global Molecular Diagnostics Point of Care Market Growth (Status and Outlook) 2025-2031

Publisher LP Information, Inc.
Published Jun 09, 2025
Length 152 Pages
SKU # LPI20070193

Description

The global Molecular Diagnostics Point of Care market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.

United States market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Molecular Diagnostics Point of Care is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Molecular Diagnostics Point of Care players cover Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories, Becton Dickinson and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Molecular Diagnostics Point of Care Industry Forecast” looks at past sales and reviews total world Molecular Diagnostics Point of Care sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics Point of Care sales for 2025 through 2031. With Molecular Diagnostics Point of Care sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics Point of Care industry.

This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics Point of Care landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Diagnostics Point of Care portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnostics Point of Care market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics Point of Care and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics Point of Care.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Point of Care market by product type, application, key players and key regions and countries.

Segmentation by Type:
Assays and Kits
Instruments and Analyzers
Software and Services
Others

Segmentation by Application:
Tumor
Hematology
Endocrinology
Infectious Disease
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Abaxis
Bayer Healthcare
Bio-Rad Laboratories
Becton Dickinson and Company
Binx Health
BioMerieux
Co-Diagnostics
DanaherCorporation
Dako
F. Hoffmann
OraSure Technologies
Roche Diagnostics
Nipro Diagnostics
Genestat
Meridian Bioscience
Molbio Diagnostics
Siemens Healthcare
Thermo Fisher Scientific
Visby Medical
Wuhan Easy Diagnosis Biomedicine
Beijing Tiandz
Beijing Content

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

152 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Molecular Diagnostics Point of Care Market Size by Player
4 Molecular Diagnostics Point of Care by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Molecular Diagnostics Point of Care Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us